Activ Surgical completes first AI-enabled case with ActivSight intelligent light

Boston-based Activ Surgical designed ActivSight to provide enhanced visualization and real-time on-demand surgical insights in the operating room. The easy-to-adapt model seamlessly attaches to laparoscopic and robotic systems. Activ Surgical received CE mark approval for ActivSight in December 2022. The FDA cleared the technology in April 2021. The company aims to transform the surgical experience using emerging technologies and data.